Skip to playerSkip to main content
  • 2 years ago
Jim Cramer has expressed his confidence in Eli Lilly, LLY, citing the company’s diverse drug portfolio and the recent endorsement of its Alzheimer’s treatment by FDA advisors.

Category

🗞
News
Be the first to comment
Add your comment

Recommended